LHRH-Agonist treatment in clinical and experimental human breast cancer

This publication has 18 references indexed in Scilit:

• Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer
  Breast Cancer Research and Treatment, 1984
• Therapeutic potential of the lh-rh agonist zoladex (ICI 118630) in the treatment of advanced breast cancer in pre and postmenopausal women
  Journal of Steroid Biochemistry, 1984
• LHRH-agonist treatment in metastatic prostate carcinoma
  European Journal of Cancer and Clinical Oncology, 1984
• Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects
  European Journal of Cancer and Clinical Oncology, 1984
• 286 An analogue of LHRH antagonizes the growth-stimulating effect of oestradiol on human breast cancer cells in culture (MCF-7)
  Journal of Steroid Biochemistry, 1983
• SUSTAINED GONADAL SUPPRESSION IN FERTILE WOMEN WITH THE LHRH AGONIST BUSERELIN
  Clinical Endocrinology, 1983
• The presence of LHRH‐like receptors in Dunning R3327H prostate tumors
  FEBS Letters, 1983
• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone
  Biochemical and Biophysical Research Communications, 1980
• THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOUR
  Clinical Endocrinology, 1980